Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Chi

Showing results (121-130 of 410) with videos related to

Pageof 41
Sort By:
Clinical Genitourinary Cancer|July 5, 2014
A phase II study of GW786034 (pazopanib) with or without bicalutamide in patients with castration-resistant prostate cancerSrikala S Sridhar, Anthony M Joshua, Richard Gregg, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 18, 2023
Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapySara Harsini, Don Wilson, Heather Saprunoff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 8, 2010
Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapiesC Kollmannsberger, S Tyldesley, C Moore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancerK N Chi, M E Gleave, R Klasa, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2008
Comparison of successive transition states for folding reveals alternative early folding pathways of two homologous proteinsNicoletta Calosci, Celestine N Chi, Barbara Richter, et al.
Structure (London, England : 1993)|July 2, 2013
Energetic pathway sampling in a protein interaction domainGreta Hultqvist, S Raza Haq, Avinash S Punekar, et al.
Biomolecular NMR Assignments|October 25, 2018
Backbone and side-chain chemical shift assignments of full-length, apo, human Pin1, a phosphoprotein regulator with interdomain allosteryAlexandra Born, Parker J Nichols, Morkos A Henen, et al.
Angewandte Chemie (International Ed. in English)|August 16, 2020
Protein Allostery at Atomic ResolutionDean Strotz, Julien Orts, Harindranath Kadavath, et al.
Cancer|October 18, 2007
Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancerGuru Sonpavde, Kim N Chi, Thomas Powles, et al.
JCO Precision Oncology|September 11, 2020
Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate CancerSinja Taavitsainen, Matti Annala, Elisa Ledet, et al.
Pageof 41

Showing results (121-130 of 410) with videos related to

Sort By:
Pageof 41
Clinical Genitourinary Cancer|July 5, 2014
A phase II study of GW786034 (pazopanib) with or without bicalutamide in patients with castration-resistant prostate cancerSrikala S Sridhar, Anthony M Joshua, Richard Gregg, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 18, 2023
Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapySara Harsini, Don Wilson, Heather Saprunoff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 8, 2010
Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapiesC Kollmannsberger, S Tyldesley, C Moore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancerK N Chi, M E Gleave, R Klasa, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2008
Comparison of successive transition states for folding reveals alternative early folding pathways of two homologous proteinsNicoletta Calosci, Celestine N Chi, Barbara Richter, et al.
Structure (London, England : 1993)|July 2, 2013
Energetic pathway sampling in a protein interaction domainGreta Hultqvist, S Raza Haq, Avinash S Punekar, et al.
Biomolecular NMR Assignments|October 25, 2018
Backbone and side-chain chemical shift assignments of full-length, apo, human Pin1, a phosphoprotein regulator with interdomain allosteryAlexandra Born, Parker J Nichols, Morkos A Henen, et al.
Angewandte Chemie (International Ed. in English)|August 16, 2020
Protein Allostery at Atomic ResolutionDean Strotz, Julien Orts, Harindranath Kadavath, et al.
Cancer|October 18, 2007
Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancerGuru Sonpavde, Kim N Chi, Thomas Powles, et al.
JCO Precision Oncology|September 11, 2020
Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate CancerSinja Taavitsainen, Matti Annala, Elisa Ledet, et al.
Pageof 41